Brachytherapy devices are used to treat cancer of prostate, breast among others. The therapy uses radioactive sources by placing them directly into right next to the area that requires treatment. The radioactive source helps technician to deliver a high dose with the slight impact on the surrounding normal tissue. The treatment is also used to treat soft tissue sarcomas and other types of cancer.
The brachytherapy devices market is expected to grow exponentially due to the key factors such as rising developments in the technology which enables players to develop devices. The developments in research has helps players to develop thin tubes like devices to deliver radiation directly to the tumor site. The rise in prevalence of cancer are creating opportunities for the players to develop such more devices for the brachytherapy.
The “Global Brachytherapy Devices Market Analysis to 2025” is a specialized and in-depth study of the medical device industry with a focus on the global market trend. The report aims to provide an overview of global brachytherapy devices market with detailed market segmentation by type, application, and geography. The global brachytherapy devices market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the market.
The segmentation of the market is classified as type and application. The type segment is segmented into high dose rate (HDR) brachytherapy and low dose rate (LDR) brachytherapy. The application segment is segmented gynecological cancer, prostate cancer, breast cancer and others.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Brachytherapy devices market based on Type and application. It also provides market size and forecast till 2025 for overall Brachytherapy devices market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 counties globally along with current trend and opportunities prevailing in the region.
North America is the largest market for the brachytherapy followed by Europe. According to the American Cancer Society, in recent year the incidence rate of breast cancer is stable in white women however it is increasing by 0.3% per year in African American women. In addition, it is very common in women in contrast to the other races. Asia Pacific is the fastest growing market for the brachytherapy market as the incidences are growing in this region.
The report analyzes factors affecting market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America.
The report also includes the profiles of key brachytherapy devices manufacturing companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 3 years, key development in past five years. Some of the key players influencing the market are Eckert & Ziegler BEBIG., Elekta AB, IsoRay Inc., Bard Biopsy Systems, Theragenics Corporation, Huiheng Medical Inc., iCAD Inc., Sun Nuclear Corporation, CIVCO Medical Solutions, and Varian Medical Systems, Inc.
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.